ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements
Hipolin Limited has scheduled its 33rd Annual General Meeting for September 29, 2026, to transact ordinary and special business, including director appointments and re-designations.
Hipolin redesigned Mr. Shailesh J Shah as Executive Managing Director at its 7 September board meeting. The 33rd AGM is set for 29 September 2026.
Promoter Rajasvee Sagar Shah sold 2,93,560 shares of Hipolin Ltd, representing a 9.38% stake. The transaction was executed via the open market on August 20, 2026.
Hipolin Limited clarifies the resignation of its Managing Director, Mr. Prafulla Gattani, and the sad demise of Independent Director, Mr. Umeshchandra P Mehta.
Promoter Rajasvee Sagar Shah sold 2,93,560 shares of Hipolin Ltd via open market. This divestment reduced the promoter's holding by 9.38%.
Hipolin Limited announced the passing of Independent Director Mr. Umeshchandra P Mehta. He ceased to be a director effective August 14, 2026.
Hipolin Ltd reported revenue from operations of ₹5.2 Cr (+57.6% YoY) and net profit of ₹0 Cr for Q1 FY27.
Hipolin Limited has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Hipolin Ltd provided clarifications to BSE regarding its SEBI LODR declarations. The company confirmed the unmodified auditor's opinion for FY2026.
Hipolin Ltd reported revenue from operations of ₹3.9 Cr (-11.4% YoY) and net profit of ₹0 Cr for Q4 FY26.
Hipolin Ltd approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The results reflect the company's full-year operational performance.
Hipolin Ltd has scheduled a board meeting on May 29, 2026, to approve audited financial results. Directors will also review the statutory audit report.
Hipolin Limited confirmed its exemption from submitting the Annual Secretarial Compliance Report for FY 2025-26. The company remains below regulatory capital and net worth thresholds.
Hipolin Ltd (BSE: 530853) submitted an initial disclosure confirming it does not meet the criteria for a 'Large Corporate' under SEBI's debt borrowing framework. The company reported outstanding borrowings of ₹0.74 Crore as of March 31, 2026. This disclosure is a routine regulatory compliance filing.
Hipolin Ltd reported net profit of ₹0 Cr for Q3 FY26.